Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
暂无分享,去创建一个
W. Kraus | G. Ginsburg | D. Voora | S. Haga | L. Orlando | Josephine H. Li | S. Joy
[1] Robert Cook-Deegan,et al. Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.
[2] J. Breslow,et al. How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy? , 2012, Current Atherosclerosis Reports.
[3] R. McPherson,et al. Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. , 2009, Journal of the American College of Cardiology.
[4] Marc A Pfeffer,et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. , 2008, Journal of the American College of Cardiology.
[5] J. Weinman,et al. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.
[6] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[7] P. Ridker,et al. Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy. , 2013, American heart journal.
[8] R. Collins,et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.
[9] Steve Evans,et al. The DEDUCE Guided Query tool: Providing simplified access to clinical data for research and quality improvement , 2011, J. Biomed. Informatics.
[10] J. Hsu,et al. Patients' perspectives on nonadherence to statin therapy: a focus-group study. , 2010, The Permanente journal.
[11] S. Haga,et al. The potential impact of pharmacogenetic testing on medication adherence , 2013, The Pharmacogenomics Journal.
[12] A. Morris,et al. Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go‐DARTS Study , 2011, Clinical pharmacology and therapeutics.
[13] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[14] Alexander Turchin,et al. Accuracy of Electronically Reported “Meaningful Use” Clinical Quality Measures , 2013, Annals of Internal Medicine.
[15] Joseph Thomas,et al. Relationships Between Beliefs about Medications and Nonadherence to Prescribed Chronic Medications , 2006, The Annals of pharmacotherapy.
[16] L. Rallidis,et al. Managing the underestimated risk of statin-associated myopathy. , 2012, International journal of cardiology.
[17] R. Hegele,et al. Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference. , 2011, The Canadian journal of cardiology.
[18] T. Jacobson. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia. , 2008, Mayo Clinic proceedings.
[19] L. Puccetti,et al. Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study. , 2010, Atherosclerosis.
[20] J. Foody,et al. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. , 2011, The American journal of cardiology.
[21] F. Frueh,et al. PATIENT KNOWLEDGE OF PHARMACOGENETIC INFORMATION IMPROVES ADHERENCE TO STATIN THERAPY: RESULTS OF THE ADDITIONAL KIF6 RISK OFFERS BETTER ADHERENCE TO STATINS (AKROBATS) TRIAL , 2012 .
[22] M. Sprangers,et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. , 2012, The American journal of cardiology.
[23] P Michael Ho,et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.
[24] J. Spertus,et al. Exploring Patients' Reasons for Discontinuance of Heart Medications , 2009, The Journal of cardiovascular nursing.
[25] E. Spatz,et al. Statin myopathy: A common dilemma not reflected in clinical trials , 2011, Cleveland Clinic Journal of Medicine.
[26] R. Collins,et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. , 2011, Journal of the American College of Cardiology.
[27] Alexander F. Wilson,et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. , 2010, Journal of the American College of Cardiology.
[28] Claude Lenfant,et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. , 2002, Journal of the American College of Cardiology.
[29] G. Ginsburg,et al. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. , 2009, Journal of the American College of Cardiology.
[30] Matthew K Ito,et al. Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. , 2012, Journal of clinical lipidology.
[31] J. Weinman,et al. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .
[32] M. Sabatine,et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. , 2008, Journal of the American College of Cardiology.
[33] Muhammad Mamdani,et al. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.
[34] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.